Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 22Breast 11Tumor-Agnostic 3Head & Neck 2Other solid neoplasm 1Other 1

Conditions

Obesity 1Neoplasms 1

Interventions

Exercise 22Methods 13Educational Status 11Early Intervention, Educational 11Counseling 10Standard of Care 8Diet Therapy 8Nutrition Assessment 7Resistance Training 6Psychiatric Rehabilitation 5Diet 5Cryotherapy 5Caloric Restriction 5Mindfulness-Based Stress Reduction 4Metformin 4Low-Level Light Therapy 4Interviews as Topic 4Diet, Mediterranean 4Surveys and Questionnaires 3Electroacupuncture 3Cognitive Behavioral Therapy 3Yoga 2Vitamin D 2Transcutaneous Electric Nerve Stimulation 2Therapeutics 2Sugars 2Specimen Handling 2Robotic Surgical Procedures 2Propolis 2Probiotics 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Capecitabine × Other × Clear all
NCT01828554 2019-11-25

Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight

University of Wisconsin, Madison

Phase NA Completed
8 enrolled 7 charts
Other

Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡